延伸 ：Dambisa Moyo: Is China the new idol for emerging economies? （中文字幕）
The developed world holds up the ideals of capitalism, democracy and political rights for all. Those in emerging markets often don't have that luxury. In this powerful talk, economist Dambisa Moyo makes the case that the west can't afford to rest on its laurels and imagine others will blindly follow. Instead, a different model, embodied by China, is increasingly appealing. A call for open-minded political and economic cooperation in the name of transforming the world.
Western companies last year began selling some of their hottest cancer drugs, called PD-1 inhibitors, with much fanfare in China. But rather than quickly conquering the mainland market, American drugmakers have found themselves facing a surprising challenge: local competitors. Chinese companies are introducing patent cancer therapies in their home market bas on PD-1 inhibitors, which use the body’s immune system to fight tumors. They’re doing it at far lower prices—sometimes a third of what U.S. drugmakers charge—which will likely give them a leg up at home. their ambition go far beyond the mainland, with several already preparing to sell their medicines in U.S.
發表於 
返回列表
